US Stock MarketDetailed Quotes

BOLT Bolt Biotherapeutics

Watchlist
  • 0.637
  • +0.011+1.79%
Trading Nov 29 10:13 ET
24.39MMarket Cap-372P/E (TTM)

Bolt Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
16.62%-13.97M
-6.82%-16.14M
28.41%-16.75M
9.12%-69.53M
20.54%-14.27M
-24.52%-16.75M
27.30%-15.11M
3.76%-23.4M
-34.06%-76.5M
-0.89%-17.95M
Net income from continuing operations
6.65%-15.18M
-17.38%-21.2M
36.33%-10.81M
21.45%-69.2M
10.47%-17.9M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
10.64%-88.1M
26.37%-20M
Depreciation and amortization
-4.76%440K
-0.22%457K
-1.93%458K
11.28%1.85M
1.08%467K
5.24%462K
12.25%458K
30.81%467K
39.65%1.67M
27.98%462K
Other non cash items
7.93%803K
7.80%788K
7.51%773K
-8.47%2.95M
7.52%758K
9.09%744K
9.60%731K
-38.60%719K
-62.34%3.23M
29.60%705K
Change In working capital
78.53%-578K
242.47%1.77M
8.55%-8.44M
-222.67%-9.86M
298.84%1.54M
-152.97%-2.69M
128.52%518K
-66.32%-9.23M
-114.91%-3.06M
-114.37%-774K
-Change in prepaid assets
131.34%398K
396.21%2.23M
90.56%-130K
49.72%-454K
1,017.89%1.74M
-203.42%-1.27M
150.84%449K
35.05%-1.38M
-58.98%-903K
-102.87%-190K
-Change in payables and accrued expense
-46.31%444K
-22.65%915K
46.39%-3.54M
-223.30%-3.41M
313.94%1.19M
-85.15%827K
270.22%1.18M
-176.38%-6.61M
-58.54%2.77M
152.28%287K
-Change in other current liabilities
-16.10%-714K
-16.55%-676K
-24.55%-695K
13.37%-2.39M
19.04%-638K
-21.78%-615K
-20.58%-580K
43.41%-558K
-134.89%-2.76M
-127.75%-788K
-Change in other working capital
56.79%-706K
-29.78%-693K
-496.05%-4.07M
-66.79%-3.61M
-809.64%-755K
-35.15%-1.63M
34.80%-534K
-1,239.22%-683K
-113.88%-2.16M
75.37%-83K
Cash from discontinued investing activities
Operating cash flow
16.62%-13.97M
-6.82%-16.14M
28.41%-16.75M
9.12%-69.53M
20.54%-14.27M
-24.52%-16.75M
27.30%-15.11M
3.76%-23.4M
-34.06%-76.5M
-0.89%-17.95M
Investing cash flow
Cash flow from continuing investing activities
35.39%17.14M
32.57%18M
-64.81%10.2M
22.77%71.04M
-3.81%15.81M
772.97%12.66M
1,664.52%13.58M
-29.02%28.99M
124.92%57.86M
-21.86%16.44M
Net PPE purchase and sale
164.85%107K
--0
--0
89.45%-206K
96.74%-6K
77.55%-165K
92.54%-32K
99.50%-3K
16.47%-1.95M
67.26%-184K
Net investment purchase and sale
32.82%17.03M
32.26%18M
-64.81%10.2M
19.11%71.24M
-4.84%15.82M
486.86%12.82M
3,200.68%13.61M
-30.05%28.99M
126.02%59.82M
-23.04%16.62M
Cash from discontinued investing activities
Investing cash flow
35.39%17.14M
32.57%18M
-64.81%10.2M
22.77%71.04M
-3.81%15.81M
772.97%12.66M
1,664.52%13.58M
-29.02%28.99M
124.92%57.86M
-21.86%16.44M
Financing cash flow
Cash flow from continuing financing activities
0
-49.70%253K
-26.39%106K
0
-99.84%503K
-70.91%144K
Net common stock issuance
--0
----
----
-49.70%253K
-26.39%106K
--0
----
----
-99.81%503K
-70.91%144K
Cash from discontinued financing activities
Financing cash flow
--0
----
----
-49.70%253K
-26.39%106K
--0
----
----
-99.84%503K
-70.91%144K
Net cash flow
Beginning cash position
-46.94%7.97M
-63.25%6.03M
16.34%12.58M
-62.66%10.81M
-10.32%10.93M
-37.91%15.02M
-64.02%16.4M
-62.66%10.81M
307.32%28.95M
-51.69%12.18M
Current changes in cash
177.54%3.17M
240.07%1.94M
-217.10%-6.55M
109.74%1.77M
220.17%1.65M
65.91%-4.09M
93.53%-1.39M
-66.39%5.59M
-183.05%-18.14M
-136.77%-1.37M
End cash Position
1.96%11.14M
-46.94%7.97M
-63.25%6.03M
16.34%12.58M
16.34%12.58M
-10.32%10.93M
-37.91%15.02M
-64.02%16.4M
-62.66%10.81M
-62.66%10.81M
Free cash flow
17.19%-14.01M
-6.59%-16.14M
28.42%-16.75M
11.12%-69.73M
21.31%-14.27M
-19.23%-16.91M
28.62%-15.14M
6.09%-23.4M
-32.07%-78.46M
1.20%-18.14M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 16.62%-13.97M-6.82%-16.14M28.41%-16.75M9.12%-69.53M20.54%-14.27M-24.52%-16.75M27.30%-15.11M3.76%-23.4M-34.06%-76.5M-0.89%-17.95M
Net income from continuing operations 6.65%-15.18M-17.38%-21.2M36.33%-10.81M21.45%-69.2M10.47%-17.9M25.29%-16.26M20.33%-18.06M28.29%-16.98M10.64%-88.1M26.37%-20M
Depreciation and amortization -4.76%440K-0.22%457K-1.93%458K11.28%1.85M1.08%467K5.24%462K12.25%458K30.81%467K39.65%1.67M27.98%462K
Other non cash items 7.93%803K7.80%788K7.51%773K-8.47%2.95M7.52%758K9.09%744K9.60%731K-38.60%719K-62.34%3.23M29.60%705K
Change In working capital 78.53%-578K242.47%1.77M8.55%-8.44M-222.67%-9.86M298.84%1.54M-152.97%-2.69M128.52%518K-66.32%-9.23M-114.91%-3.06M-114.37%-774K
-Change in prepaid assets 131.34%398K396.21%2.23M90.56%-130K49.72%-454K1,017.89%1.74M-203.42%-1.27M150.84%449K35.05%-1.38M-58.98%-903K-102.87%-190K
-Change in payables and accrued expense -46.31%444K-22.65%915K46.39%-3.54M-223.30%-3.41M313.94%1.19M-85.15%827K270.22%1.18M-176.38%-6.61M-58.54%2.77M152.28%287K
-Change in other current liabilities -16.10%-714K-16.55%-676K-24.55%-695K13.37%-2.39M19.04%-638K-21.78%-615K-20.58%-580K43.41%-558K-134.89%-2.76M-127.75%-788K
-Change in other working capital 56.79%-706K-29.78%-693K-496.05%-4.07M-66.79%-3.61M-809.64%-755K-35.15%-1.63M34.80%-534K-1,239.22%-683K-113.88%-2.16M75.37%-83K
Cash from discontinued investing activities
Operating cash flow 16.62%-13.97M-6.82%-16.14M28.41%-16.75M9.12%-69.53M20.54%-14.27M-24.52%-16.75M27.30%-15.11M3.76%-23.4M-34.06%-76.5M-0.89%-17.95M
Investing cash flow
Cash flow from continuing investing activities 35.39%17.14M32.57%18M-64.81%10.2M22.77%71.04M-3.81%15.81M772.97%12.66M1,664.52%13.58M-29.02%28.99M124.92%57.86M-21.86%16.44M
Net PPE purchase and sale 164.85%107K--0--089.45%-206K96.74%-6K77.55%-165K92.54%-32K99.50%-3K16.47%-1.95M67.26%-184K
Net investment purchase and sale 32.82%17.03M32.26%18M-64.81%10.2M19.11%71.24M-4.84%15.82M486.86%12.82M3,200.68%13.61M-30.05%28.99M126.02%59.82M-23.04%16.62M
Cash from discontinued investing activities
Investing cash flow 35.39%17.14M32.57%18M-64.81%10.2M22.77%71.04M-3.81%15.81M772.97%12.66M1,664.52%13.58M-29.02%28.99M124.92%57.86M-21.86%16.44M
Financing cash flow
Cash flow from continuing financing activities 0-49.70%253K-26.39%106K0-99.84%503K-70.91%144K
Net common stock issuance --0---------49.70%253K-26.39%106K--0---------99.81%503K-70.91%144K
Cash from discontinued financing activities
Financing cash flow --0---------49.70%253K-26.39%106K--0---------99.84%503K-70.91%144K
Net cash flow
Beginning cash position -46.94%7.97M-63.25%6.03M16.34%12.58M-62.66%10.81M-10.32%10.93M-37.91%15.02M-64.02%16.4M-62.66%10.81M307.32%28.95M-51.69%12.18M
Current changes in cash 177.54%3.17M240.07%1.94M-217.10%-6.55M109.74%1.77M220.17%1.65M65.91%-4.09M93.53%-1.39M-66.39%5.59M-183.05%-18.14M-136.77%-1.37M
End cash Position 1.96%11.14M-46.94%7.97M-63.25%6.03M16.34%12.58M16.34%12.58M-10.32%10.93M-37.91%15.02M-64.02%16.4M-62.66%10.81M-62.66%10.81M
Free cash flow 17.19%-14.01M-6.59%-16.14M28.42%-16.75M11.12%-69.73M21.31%-14.27M-19.23%-16.91M28.62%-15.14M6.09%-23.4M-32.07%-78.46M1.20%-18.14M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data